OTC drug advertising to Nebraska consumers must not make deceptive cure, safety, efficacy or FDA-approval claims or promote uses beyond the label. Use for OTC drug ads, product pages, listings, displays and packaging aimed at Nebraska consumers. This guide summarizes the supplied rule information for marketing review. Use the linked official source to confirm the current text, applicability and any
Alabama's medical cannabis program (Alabama Medical Cannabis Commission (AMCC)) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Arkansas's medical cannabis program (Arkansas Medical Marijuana Commission) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Hawaii's medical cannabis program (Hawaii Department of Health — Medical Cannabis Registry) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Iowa's medical cannabis program (Iowa Department of Health and Human Services (Iowa HHS), Office of Medical Cannabidiol) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Kentucky's medical cannabis program (Kentucky Cabinet for Health and Family Services — Office of Medical Cannabis) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Louisiana's medical cannabis program (Louisiana Department of Health — Medical Marijuana Program) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Request a free compliance scan of your homepage and book a time with Warrant.